Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis

BACKGROUND: Eosinophilic granulomatosis with polyangiitis (EGPA) is a disease that is associated with severe uncontrolled eosinophilic asthma. Eosinophils play an important pathogenic role in the development of both diseases. Benralizumab is an antieosinophilic monoclonal antibody that binds to the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Pulm Med
Asıl Yazarlar: Martínez-Rivera, Carlos, Garcia-Olivé, Ignasi, Urrutia-Royo, Blanca, Basagaña-Torrento, Maria, Rosell, Antoni, Abad, Jorge
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2021
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7819231/
https://ncbi.nlm.nih.gov/pubmed/33478439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-021-01397-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller